GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (GYRE)

CUSIP: 403783103

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 6 signals
Share change
+336,107
SEC-reported price per share
$12.54
Number of holders
34
Value change
+$4,240,829
Number of buys
20
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
124,924,768

Security key

403783103

Report period

Q3 2024

Institutions

34

Top holders

10

Ownership snapshot

Top reported holders of GYRE - GYRE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $5,958,903 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $5.96M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $5.96M
GEODE CAPITAL MANAGEMENT, LLC $3.1M
VANGUARD GROUP INC $2.76M
STATE STREET CORP $1.15M
NORTHERN TRUST CORP $390.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$5,958,903
499,489 shares
— 30 Jun 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$3,099,962
259,807 shares
— 30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,763,477
231,641 shares
— 30 Jun 2024
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$1,146,211
96,078 shares
— 30 Jun 2024
NORTHERN TRUST CORP
13F
Company
13F
—
denominator unverified
$390,111
32,700 shares
— 30 Jun 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$275,476
23,091 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
34
Shares
1,610,238
Rows available
34
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2026 Across Filers

Q2 2026 holders
58
Q3 2024 holders
34
Holder diff
-24
Investor Q2 2026 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2026 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .